These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4890810)

  • 1. [Interaction between nalidixic acid and some antibacterial substances].
    Dominici A; Perini C
    Antibiotica; 1967 Sep; 5(3):212-23. PubMed ID: 4890810
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of occurrence of E. coli strains capable of transferring multiple resistance in infection of the urinary tract, and properties of some of their R factors.
    Horák V
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(2):264-6. PubMed ID: 4896912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbial spectrum and microbial resistance in ambulatory and stationary urological patients].
    Weissbach L; Tümmers H; Primavesi CA
    Z Urol Nephrol; 1970 Oct; 63(10):763-71. PubMed ID: 4994620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibacterial effect of chloramphenicol and nitrofurantoin under the effect of lysozyme].
    Ritzerfeld W; Kleining R
    Arch Hyg Bakteriol; 1968 Dec; 152(5):477-81. PubMed ID: 4907118
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitory action of nitrofurantoin on the bacteriostatic power in vitro of nalidixic acid].
    Piguet JD
    Ann Inst Pasteur (Paris); 1969 Jan; 116(1):43-8. PubMed ID: 4890584
    [No Abstract]   [Full Text] [Related]  

  • 6. The assessment of interaction between drugs by the Autobac 1 system.
    Visconti A
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):403-12. PubMed ID: 367389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity tests in various potentially pathogenic microorganisms].
    Jedicková Z; Aldová E
    Z Gesamte Inn Med; 1972 Jan; 27(1):41. PubMed ID: 4335602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative theoretical activity of antibiotics on the main gram-negative bacilli].
    Monnier J; Bourse R; Moatti N; Suc C
    Pathol Biol (Paris); 1969 Oct; 17(19):817-24. PubMed ID: 4985138
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of subinhibitory concentrations of antimicrobial agents on virulence factors of Shigella flexneri 2a and Escherichia coli O124.
    Tetz VV; Norman LL
    J Med Microbiol; 1994 Oct; 41(4):279-81. PubMed ID: 7932621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gentamycin].
    Wieser T
    Arzneimittelforschung; 1969 May; 19(5):778-80. PubMed ID: 4979307
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary tract infection.
    Robertson MH
    Br Med J; 1968 Oct; 4(5623):121-2. PubMed ID: 4880258
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant Escherichia coli.
    Dwivedi GR; Maurya A; Yadav DK; Khan F; Darokar MP; Srivastava SK
    Chem Biol Drug Des; 2015 Sep; 86(3):272-83. PubMed ID: 25476148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in virulence of Enterobacteriaceae in the presence of sub-inhibitory levels of antibiotics].
    Tets VV; Norman LL
    Antibiot Khimioter; 1991 Apr; 36(4):20-2. PubMed ID: 1892427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.
    Starcic Erjavec M; Rijavec M; Krizan-Hergouth V; Fruth A; Zgur-Bertok D
    Int J Antimicrob Agents; 2007 Nov; 30(5):436-42. PubMed ID: 17719751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of nalidixic acid on Escherichia coli growth in milk.
    Tyczyńska B; Bassalik-Chabielska L
    Acta Microbiol Pol; 1987; 36(3):221-7. PubMed ID: 2447751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies with nitrofurantoin: bacteriological studies with microorganisms causing urinary tract infections].
    Hein H
    Arzneimittelforschung; 1969 Sep; 19(9):1579-84. PubMed ID: 4981210
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics.
    Greenwood D
    J Antimicrob Chemother; 1976 Mar; 2(1):87-95. PubMed ID: 6416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research on the frequency and sensitivity of microbial species isolated from urine to some antibiotics and chemotherapeutics].
    Pitzus E
    Ig Mod; 1970; 63(7):400-19. PubMed ID: 4996878
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant Escherichia coli.
    Maurya A; Dwivedi GR; Darokar MP; Srivastava SK
    Chem Biol Drug Des; 2013 Apr; 81(4):484-90. PubMed ID: 23290001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.